• CooperCompanies to Participate in the KeyBanc Life Sciences MedTech Investor Forum

    Источник: Nasdaq GlobeNewswire / 02 мар 2021 16:15:00   America/New_York

    SAN RAMON, Calif., March 02, 2021 (GLOBE NEWSWIRE) -- CooperCompanies (NYSE: COO), will participate in the KeyBanc Life Sciences MedTech Investor Forum on Wednesday, March 24, 2021. Brian Andrews, Executive Vice President, Chief Financial Officer & Treasurer, will represent the Company in a virtual session scheduled to begin at 1:15PM ET.

    A live webcast of the Company’s session will be available on the Investor Relations section of CooperCompanies’ website at http://investor.coopercos.com. An archived audio file will be available for replay on the same webpage later in the day.

    About CooperCompanies
    CooperCompanies ("Cooper") is a global medical device company publicly traded on the NYSE (NYSE:COO). Cooper operates through two business units, CooperVision and CooperSurgical. CooperVision brings a refreshing perspective on vision care with a commitment to developing a wide range of high-quality products for contact lens wearers and providing focused practitioner support. CooperSurgical is committed to advancing the health of women, babies and families with its diversified portfolio of products and services focusing on medical devices and fertility & genomics. Headquartered in San Ramon, CA, Cooper has a workforce of more than 12,000 with products sold in over 100 countries. For more information, please visit www.coopercos.com.


    Kim Duncan
    Vice President, Investor Relations and Risk Management


    Primary Logo